Skip to contentDOMAIN PARTERS VII L P — CADENCE PHARMACEUTICALS INC insider: 74 transactions · InsiderLensDOMAIN PARTERS VII L P
- 10% owner at Orexigen Therapeutics, Inc. · on record since Dec 11, 2008
- 10% owner at CADENCE PHARMACEUTICALS INC · on record since Feb 20, 2009
- 10% owner at Clovis Oncology, Inc. · on record since Nov 21, 2011
- 10% owner at Neutral Tandem Inc · on record since Nov 19, 2013
- 10% owner at ZOGENIX, INC. · on record since Nov 22, 2010
- 10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
- 10% owner at Evoke Pharma Inc · on record since Sep 30, 2013
- 10% owner at Achaogen Inc · on record since Mar 17, 2014
- 10% owner at OBALON THERAPEUTICS INC · on record since Oct 14, 2016
- 10% owner at Neothetics, Inc. · on record since Nov 26, 2014
- 10% owner at Regado Biosciences Inc · on record since May 6, 2015
Insider trading activity of DOMAIN PARTERS VII L P
- Transactions on record
- 74
- since Dec 11, 2008
- Open-market buys
- 20
- $48.8M
- Open-market sells
- 18
- $11.4M
- Companies traded
- 9
- last filing Aug 8, 2019
Figures computed from official regulatory filings — methodology.
Companies where DOMAIN PARTERS VII L P has traded
- OBALON THERAPEUTICS INC2 tx · $1.8M · Aug 8, 2019
- Evoke Pharma Inc6 tx · $388.4K · Apr 13, 2016
- CADENCE PHARMACEUTICALS INC17 tx · $63.8M · Mar 21, 2014
- Achaogen Inc4 tx · Mar 17, 2014
- Neutral Tandem Inc6 tx · Nov 19, 2013
- Esperion Therapeutics, Inc.5 tx · $3.9M · Jul 2, 2013
- Clovis Oncology, Inc.10 tx · $22.2M · Jun 5, 2013
- Orexigen Therapeutics, Inc.16 tx · $22.5M · Dec 22, 2011
- ZOGENIX, INC.8 tx · $16.1M · Sep 20, 2011
Track record of DOMAIN PARTERS VII L P
Statistical track record
Free- Open-market buys
- 22
- Last buy
- Aug 6, 2019
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of DOMAIN PARTERS VII L P
Co-insiders of DOMAIN PARTERS VII L P
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Kamdar Kim P.CADENCE PHARMACEUTICALS INC +8
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Aug 8, 2019 | BuyD | 187,500 | 4.00 USD | $750K | SEC |
| Aug 8, 2019 | Buy | 250,000 | 4.00 USD | $1M | SEC |
| Apr 13, 2016 | Sell | -4,348 | 5.22 USD | $22.7K | SEC |
| Apr 16, 2015 | Sell | -9,832 | 7.78 USD | $76.5K | SEC |
| Apr 16, 2015 | Sell | -32,411 | 7.07 USD | $229.1K | SEC |
| Apr 16, 2015 | Sell | -7,920 | 7.58 USD | $60K | SEC |
| Mar 21, 2014 | Other | -2,972,678 | 14.00 USD | $41.6M | SEC |
| Mar 17, 2014 | OtherD | -926,321 | 0.00 USD | $0 | SEC |
| Mar 17, 2014 | Other | 1,987,049 | — | — | SEC |
| Mar 17, 2014 | OtherD | -625,065 | 0.00 USD | $0 | SEC |
| Mar 17, 2014 | OtherD | -435,663 | 0.00 USD | $0 | SEC |
| Feb 14, 2014 | ExerciseD | -1,367,020 | 0.00 USD | $0 | SEC |
| Feb 14, 2014 | Exercise | 1,367,020 | 7.84 USD | $10.7M | SEC |
| Feb 14, 2014 | Other | -765,532 | 14.00 USD | $10.7M | SEC |
| Nov 19, 2013 | OtherD | -549,833 | 0.00 USD | $0 | SEC |
| Nov 19, 2013 | OtherD | 352,351 | 0.00 USD | $0 | SEC |
| Nov 19, 2013 | Other | 3,189,058 | — | — | SEC |
| Nov 19, 2013 | OtherD | -2,283,114 | 0.00 USD | $0 | SEC |
| Nov 19, 2013 | OtherD | -356,111 | 0.00 USD | $0 | SEC |
| Nov 19, 2013 | OtherD | -590,403 | 0.00 USD | $0 | SEC |
| Sep 30, 2013 | OtherD | -1,114,327 | 0.00 USD | $0 | SEC |
| Sep 30, 2013 | Other | 1,114,327 | — | — | SEC |
| Jul 2, 2013 | OtherD | 70,042 | 0.00 USD | $0 | SEC |
| Jul 2, 2013 | OtherD | -489,320 | 0.00 USD | $0 | SEC |
| Jul 2, 2013 | Buy | 280,923 | 14.00 USD | $3.9M | SEC |